ArticleJournal of cosmetic dermatology2026
Study on the Potential Molecular Mechanism of Keloid Disease Associated With Single Cell Combined Mendelian Randomization.
Article in Journal of cosmetic dermatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundKeloids are pathological scars with incompletely understood pathogenesis. This study aims to identify the key genes and regulatory networks potentially involved in keloid formation by integrating single-cell transcriptomics (scRNA-seq), protein quantitative trait loci (pQTL), Mendelian randomization (MR) analyses, colocalization, and comprehensive functional characterization.
methodsSingle-cell RNA sequencing data (GSE181297, GSE163973) and bulk transcriptomic data (GSE145725) were obtained from the GEO database. These datasets, which included both keloid lesions and normal scar samples from distinct individuals, were subjected to rigorous quality control and cell annotation. Intercellular communication was analyzed using CellChat, and co-expression networks were constructed via hdWGCNA. To identify potential causal genes, MR analysis was performed by integrating pQTL data from the deCODE database with GWAS summary statistics (GCST90018874), followed by colocalization, sensitivity analysis, and reverse validation. Further functional characterization of potential key genes was conducted through Gene Set Enrichment Analysis (GSEA), immune infiltration analysis, transcription factor (TF) regulatory network inference, and pseudotime trajectory analysis.
results92 659 high-quality cells were retained, revealing seven major cell types with fibroblasts showing the most extensive intercellular interactions. Mendelian randomization identified 11 genes causally linked to keloid risk, with genetically determined downregulation of SSR1 and SRA1 associated with increased susceptibility. SRA1 was enriched in cell cycle, nucleocytoplasmic transport, and ribosome biogenesis in eukaryotes, while SSR1 was implicated in complement/coagulation cascades, the NOD-like receptor signaling pathway, and viral protein interaction with cytokine and cytokine receptors. Immunoinfiltration, TF network and motif analysis, and pseudotime analysis further characterized their regulatory roles in immune microenvironment modulation and cell differentiation.
conclusionsThis multi-omics study identifies SRA1 and SSR1 as potential key protective genes in keloid pathogenesis. These genes may contribute to inhibiting disease progression through modulation of cell proliferation, the immune microenvironment, and cellular signaling pathways. These findings provide novel mechanistic insights and potential immunotherapeutic targets for keloids.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.